As more people begin taking GLP-1 receptor agonists and other incretin-based drugs for glycemic control and weight management, new side effects of these treatments (both good and bad) are emerging
A 2021 review published in Biomedicine & Pharmacotherapy explains that silymarin, the main active compound in milk thistle, can:25 Regulate the cell cycle, helping to ensure proper division and replication Induce apoptosis, or programmed cell death, by which the body can eliminate mutated cells (e.g., cancer cells) Regulate the body's immune response, increasing its ability to recognize and attack cancer cells Keep tumor cells from growing and spreading Inhibit angiogenesis, the process by which tumors create new blood vessels that increase their blood supply and help them grow The review specifically discusses silymarin's therapeutic potential for gastrointestinal cancer, but as another set of researchers note, silymarin has a pleiotropic effect, meaning it can act on multiple targets.26 Again, more research may be needed, but the current science suggests that milk thistle may have fairly broad complementary utility in cancer therapy
But marine algae is the largest source of the compound
18 In the randomized, controlled trial, participants were given sucralose, D-allulose 4 grams 2 times/day, or D-allulose 7 grams 2 times/day
.png)
